NIH-funded study finds transplantation superior to treatment with immune-suppressing drug.
Bethesda, Maryland—(ENEWSPF)—January 5, 2018
By: Hillary Hoffman
New clinical trial findings show that a therapeutic regimen involving transplantation of a person’s own blood-forming stem cells can improve survival and quality of life for people with severe scleroderma, a life-threatening autoimmune disease. The regimen, known as myeloablative autologous hematopoietic stem cell transplant (HSCT), includes chemotherapy and…
